FDA Drug Recalls

Recalls / Class III

Class IIID-0629-2024

Product

Methotrexate Tablets, USP, 2.5mg, 100-count Bottle, RX Only, Distributed By: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC# 69238-1423-1

Affected lot / code info
Lot # BB29124, Exp. 02/28/2026

Why it was recalled

Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.

Recalling firm

Firm
Amneal Pharmaceuticals, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
400 Crossing Blvd Fl 3, Bridgewater, New Jersey 08807-2863

Distribution

Quantity
12,624 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2024-08-01
FDA classified
2024-08-08
Posted by FDA
2024-08-14
Status
Completed

Source: openFDA Drug Enforcement endpoint. Recall record D-0629-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.